(CBRE) CBRE - Ratings and Ratios
Advisory Services, Workplace Solutions, Real Estate Investments
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 29.3% |
| Value at Risk 5%th | 42.5% |
| Relative Tail Risk | -11.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.57 |
| Alpha | 1.80 |
| CAGR/Max DD | 1.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.468 |
| Beta | 0.975 |
| Beta Downside | 1.162 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.53% |
| Mean DD | 7.59% |
| Median DD | 6.22% |
Description: CBRE CBRE December 03, 2025
CBRE Group, Inc. (NYSE:CBRE) is a global commercial real-estate services and investment firm operating through three primary segments: Advisory Services, which provides leasing, sales, financing, property-management, valuation, and consulting to owners, investors, and occupiers; Global Workplace Solutions, delivering facilities-management, data-center, laboratory, and project-management services under the Turner & Townsend brand; and Real-Estate Investments, offering institutional investment management and development activities via the CBRE Investment Management, Trammell Crow, and Telford Homes brands. The company, founded in 1906 and headquartered in Dallas, Texas, serves markets in the U.S., U.K., and worldwide.
Key recent metrics: FY 2023 revenue reached approximately $25.5 billion, with an adjusted EBITDA margin of ~19%, driven largely by a 7% year-over-year increase in advisory-services fees. Office-space vacancy rates in major U.S. metros have risen to ~15% amid higher borrowing costs, pressuring leasing activity, while industrial occupancy remains robust at >96% due to e-commerce demand. CBRE’s exposure to interest-rate-sensitive mortgage origination makes the firm vulnerable to Fed policy shifts, but its diversified services and strong institutional client base provide a buffer.
For a deeper quantitative comparison of CBRE’s valuation and performance trends, you might explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (1.23b TTM) > 0 and > 6% of Revenue (6% = 2.36b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 0.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 3.61% (prev 3.46%; Δ 0.16pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 1.72b > Net Income 1.23b (YES >=105%, WARN >=100%) |
| Net Debt (6.39b) to EBITDA (2.41b) ratio: 2.65 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (300.3m) change vs 12m ago -2.61% (target <= -2.0% for YES) |
| Gross Margin 37.94% (prev 19.60%; Δ 18.34pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 147.3% (prev 138.1%; Δ 9.15pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.95 (EBITDA TTM 2.41b / Interest Expense TTM 210.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.32
| (A) 0.05 = (Total Current Assets 12.57b - Total Current Liabilities 11.15b) / Total Assets 28.57b |
| (B) 0.34 = Retained Earnings (Balance) 9.77b / Total Assets 28.57b |
| (C) 0.06 = EBIT TTM 1.67b / Avg Total Assets 26.71b |
| (D) 0.44 = Book Value of Equity 8.49b / Total Liabilities 19.27b |
| Total Rating: 2.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.15
| 1. Piotroski 6.50pt |
| 2. FCF Yield 2.61% |
| 3. FCF Margin 3.58% |
| 4. Debt/Equity 0.94 |
| 5. Debt/Ebitda 2.65 |
| 6. ROIC - WACC (= 0.97)% |
| 7. RoE 14.67% |
| 8. Rev. Trend 77.37% |
| 9. EPS Trend -12.74% |
What is the price of CBRE shares?
Over the past week, the price has changed by -0.63%, over one month by +3.59%, over three months by -3.28% and over the past year by +16.56%.
Is CBRE a buy, sell or hold?
- Strong Buy: 5
- Buy: 4
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CBRE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 175.5 | 9.3% |
| Analysts Target Price | 175.5 | 9.3% |
| ValueRay Target Price | 186.1 | 16% |
CBRE Fundamental Data Overview December 03, 2025
P/E Trailing = 39.3432
P/E Forward = 21.645
P/S = 1.2058
P/B = 5.5558
P/EG = 0.7984
Beta = 1.342
Revenue TTM = 39.33b USD
EBIT TTM = 1.67b USD
EBITDA TTM = 2.41b USD
Long Term Debt = 4.32b USD (from longTermDebt, last quarter)
Short Term Debt = 1.64b USD (from shortTermDebt, last quarter)
Debt = 8.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.39b USD (from netDebt column, last quarter)
Enterprise Value = 53.81b USD (47.42b + Debt 8.06b - CCE 1.67b)
Interest Coverage Ratio = 7.95 (Ebit TTM 1.67b / Interest Expense TTM 210.0m)
FCF Yield = 2.61% (FCF TTM 1.41b / Enterprise Value 53.81b)
FCF Margin = 3.58% (FCF TTM 1.41b / Revenue TTM 39.33b)
Net Margin = 3.12% (Net Income TTM 1.23b / Revenue TTM 39.33b)
Gross Margin = 37.94% ((Revenue TTM 39.33b - Cost of Revenue TTM 24.41b) / Revenue TTM)
Gross Margin QoQ = 19.40% (prev 93.66%)
Tobins Q-Ratio = 1.88 (Enterprise Value 53.81b / Total Assets 28.57b)
Interest Expense / Debt = 0.62% (Interest Expense 50.0m / Debt 8.06b)
Taxrate = 18.69% (91.0m / 487.0m)
NOPAT = 1.36b (EBIT 1.67b * (1 - 18.69%))
Current Ratio = 1.13 (Total Current Assets 12.57b / Total Current Liabilities 11.15b)
Debt / Equity = 0.94 (Debt 8.06b / totalStockholderEquity, last quarter 8.54b)
Debt / EBITDA = 2.65 (Net Debt 6.39b / EBITDA 2.41b)
Debt / FCF = 4.55 (Net Debt 6.39b / FCF TTM 1.41b)
Total Stockholder Equity = 8.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.30% (Net Income 1.23b / Total Assets 28.57b)
RoE = 14.67% (Net Income TTM 1.23b / Total Stockholder Equity 8.37b)
RoCE = 13.15% (EBIT 1.67b / Capital Employed (Equity 8.37b + L.T.Debt 4.32b))
RoIC = 9.26% (NOPAT 1.36b / Invested Capital 14.66b)
WACC = 8.29% (E(47.42b)/V(55.48b) * Re(9.61%) + D(8.06b)/V(55.48b) * Rd(0.62%) * (1-Tc(0.19)))
Discount Rate = 9.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.35%
[DCF Debug] Terminal Value 72.93% ; FCFE base≈1.24b ; Y1≈1.25b ; Y5≈1.35b
Fair Price DCF = 61.37 (DCF Value 18.26b / Shares Outstanding 297.6m; 5y FCF grow 0.56% → 3.0% )
EPS Correlation: -12.74 | EPS CAGR: -2.93% | SUE: 2.86 | # QB: 5
Revenue Correlation: 77.37 | Revenue CAGR: 4.98% | SUE: 0.82 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.05 | Chg30d=-0.032 | Revisions Net=+0 | Analysts=6
EPS next Year (2026-12-31): EPS=7.32 | Chg30d=+0.006 | Revisions Net=+8 | Growth EPS=+15.5% | Growth Revenue=+8.5%
Additional Sources for CBRE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle